See How Many Clients You're Missing Each Month

Simply enter your business email & Topline AI Agent will show you.

Bio

Generated by
Topline AI
Dr. Maren Schinz is a seasoned expert in neuro-oncology, medical writing, and neuroscience with a strong background in clinical research, project management, and molecular biology. She has worked in various roles, including innovation in technology and research, founder, guest lecturer, advisor, and CEO. Dr. Schinz holds a promotion in biochemistry/molecular biology from Charité - Universitätsmedizin Berlin and a diploma in neurobiology/neuroscience from Freie Universität Berlin.

Credentials

  • certified SRUM MASTER
    Scrum.org
    Jun, 2020
    - Apr, 2026

Experience

    • Innovation in Technology & Research
      • Feb 2021 - Present
      • Schweiz

      The DCB (Global Center for Technology Innovation in Diabetes) is a private and independent Swiss foundation. DCB supports research and projects in the field of diabetes technology worldwide by providing expertise, access to clinical research facilities and its own laboratories, as well as financial resources. The goal is to bring them a big step closer to market entry in a collaborative partnership. The work of the DCB is non-profit – the goals are new insights and innovations around diabetes management as well as a vibrant community.My mission is to change the living with diabetes by connecting innovative diabetes technology, research, the community and patient entrepreneurs.

  • Beyond Diagnostics
    • Zurich, Switzerland
    • Founder
      • Jan 2024 - Present
      • Zurich, Switzerland

      Beyond Diagnostics develops AI-powered POC tests of medications to achieve real-time control of treatment efficacy at home.

    • Guest Lecturer - PPI in Medt-tech development
      • Apr 2024 - Present

    • Lecturer - Innovation & Co-Creation
      • May 2022 - Present
      • Switzerland

      Lecturer in the Master of Advanced Studies in eHealth program, with modules on User-centric Innovation and Co-Creation, reflecting a fusion of academic research and practical insights in healthcare innovation.

    • Advisor Digital Health Nation NTN Booster
      • Mar 2022 - Present
      • Switzerland

      Digital Health Nation is an NTN Innovation Booster powered by Innosuisse. They aim at transforming and improving the Swiss healthcare system, but more importantly, patients’ lives.

    • CEO & Founder
      • Nov 2016 - Mar 2021

      mysugarcase is a multi awarded start-up that designs and produces medical bags that offers a unique and innovative solution that empowers individuals living with chronic conditions to eliminate the uncertainty about the storage, transport conditions and public image of their medications. The cases are perfectly matched to a life with a chronic disease and characterized by the combination of quality, style and functionality. Therefore mysugarcase applies the latest and most innovative designs and technologies to meet patient needs.

    • EFPIA Disclosure Code implementation Lead
      • Jan 2015 - Nov 2016

      Global Innovative Pharma (GIP) - ComplianceProject: EFPIA Disclosure Code implementation • Lead Swiss Country Project Team • Coordinate the data clarification process • Manage communication at country level

    • Junior Marketing Manager - CV Metabolic - Global Innovative Pharma
      • Jan 2015 - Aug 2016

      Global Innovative Pharma (GIP) - Cardiovascular/ Metabolic • Support strategic launch Eliquis (Apixaban)• Support strategic growth Champix (Vareniclin)

    • Country Compliance Project Management Postgraduate Internship - Global Innovative Pharma
      • Sep 2014 - Dec 2014

      Global Innovative Pharma (GIP)• Country Management/ Compliance Projects• Developing Crisis Management Plan • Contribute to the EFPIA Disclosure Code Implementation Project

    • Germany
    • Hospitals and Health Care
    • 700 & Above Employee
    • Scientific assistant - Doctorate program (Dr. rer. nat.)
      • Apr 2010 - Feb 2014

      Investigation of new and innovativ treatments of multiple brain tumor entities and to reach new findings in neurological and metabolic disease mechanism. Main research topic: Influence of the Wnt signaling pathway on the neural development and medulloblastoma pathogenesis

    • Scientific assistant
      • Jun 2009 - Apr 2010

      Molecularbiology and clinical approaches to find compounds for the cure of malignant nerve sheath tumours (MPNST) - initial proof of drug testing in vitro.

    • Project Management Trainee
      • Mar 2009 - Jun 2009
      • Berlin , Germany

      Springer Science + Business Media - Medical editorial departmentIntensive experience in medical writing at the medical editorial department at the Springer Science+Business Media publishing company

  • greateyes GmbH
    • Berlin, Germany
    • Co-Founder and Project Manager
      • Jan 2008 - Mar 2009
      • Berlin, Germany

      Co-Founder and project manager for a start-up that developed high definition cameras for imaging and spectroscopy.

Education

  • 2023 - 2024
    FHGR Fachhochschule Graubünden
    CAS Artificial Intelligence
  • 2009 - 2013
    Charité - Universitätsmedizin Berlin
    Promotion, Biochemistry / Molecularbiology
  • 2005 - 2008
    Freie Universität Berlin
    Diplom, Neurobiology/ Neuroscience
  • 2002 - 2005
    Universität Osnabrück
    Vordiplom - comparable to B.Sc., Biology - Life Science

Suggested Services

This profile is unclaimed. These are suggested service rates with 0% commision upon successful connection

Industry Focus. “Medical Equipment Manufacturing”

Looking to Create a Custom Project?

Need a custom project? We'll create a solution designed specifically for your project.

Get Started

References

Social Profiles

Community

You need to have a working account to view this content. Click here to join now

Similar Profiles